
Mark Zafereo
Physician · University of Texas M D Anderson Cancer Center
Credentials: · · · ·
History
Research
Review · JAMA · 2024 · 655 citations
Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019
JAMA Oncology · 2020 · Last of 17 authors · 299 citations
Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review
Review · Advances in Therapy · 2020 · 223 citations

76 papers

61 papers

49 papers

46 papers

46 papers · 22 as a fellow
- GR
43 papers

38 papers · 3 as a fellow
- ES
35 papers
Clinical trials
- 2025–2030
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
- 2021–2026
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
- 2021–2027
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center




